Neurodegenerative Diseases · 2005 · 23 citations · 45 references
Life SciencesGeneticsMolecular GeneticsDementiaHuman GeneticsNeurogeneticsAlzheimer DiseaseDementia GeneticsFrontotemporal DementiaMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersAlzheimer Disease Tau PathologyCerebrospinal Fluid TauLinkage Disequilibrium PatternsSingle-nucleotide Polymorphism AnalysisSingle-nucleotide Polymorphism VariationTau HyperphosphorylationTauopathy Genetics
<i>Background:</i> Recent studies have described <i>Saitohin</i><i>(STH),</i> a gene located in the human <i>TAU</i> gene. The corresponding protein shows a similar tissue expression to tau, which is involved in many neurodegenerative disorders including Alzheimer’s disease (AD), frontotemporal dementia (FTD) and Parkinson’s disease (PD). A single nucleotide polymorphism in the <i>STH</i> gene has been suggested to be involved in sporadic AD and is in complete linkage disequilibrium with the <i>TAU</i> haplotype H1. <i>Objective:</i> A case-control study was performed to further explore the possible involvement of the <i>STH</i> Q7R polymorphism and the extended <i>TAU</i> haplotype in AD, FTD or PD. <i>Methods:</i> Patients with AD (n = 398), FTD (n = 96) and PD (n = 105), and controls (n = 186) were genotyped for the <i>STH</i> polymorphism and/or the <i>TAU</i> haplotype. Genotype data were related to levels of total-tau, phospho-tau and Aβ<sub>1–42</sub> in cerebral spinal fluid (CSF) in more than 300 AD patients and to an amount of senile plaques and neurofibrillary tangles in the frontal cortex and hippocampus in patients with autopsy-confirmed AD. <i>Results:</i> The <i>STH</i> Q7R polymorphism and the <i>TAU</i> haplotype were in complete linkage disequilibrium in all patients (AD and FTD) and controls investigated for both genes. There were no significant differences in genotype or allele distributions in AD, FTD or PD cases compared to controls. Neither <i>TAU</i> haplotype nor <i>STH</i> influenced CSF levels of total-tau, phospho-tau and Aβ<sub>1–42</sub> significantly. In AD patients with neuropathological scores of plaque and tangles, no associations with <i>TAU</i> haplotype and <i>STH</i> were found. <i>Conclusion:</i> We found no evidence that could support a major pathogenic role of <i>STH</i> and <i>TAU</i> haplotype in AD, FTD or PD.
45
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Practical Statistics for Medical Research.
Sophie Walter, Daniel Altman · Biometrics · 1992 · 11.7K citations
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Mike Hutton, Corinne Lendon, Patrizia Rizzu et al. · Nature · 1998 · 3.5K citations
Life Sciences, Genetics, Neurology +14